195 related articles for article (PubMed ID: 26958110)
1. Cervical cancer control and prevention in Malawi: need for policy improvement.
Maseko FC; Chirwa ML; Muula AS
Pan Afr Med J; 2015; 22():247. PubMed ID: 26958110
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
4. Health systems challenges in cervical cancer prevention program in Malawi.
Maseko FC; Chirwa ML; Muula AS
Glob Health Action; 2015; 8():26282. PubMed ID: 25623612
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors.
Chidyaonga-Maseko F; Chirwa ML; Muula AS
Pan Afr Med J; 2015; 21():231. PubMed ID: 26523173
[TBL] [Abstract][Full Text] [Related]
8. Coming of age? Women's sexual and reproductive health after twenty-one years of democracy in South Africa.
Cooper D; Harries J; Moodley J; Constant D; Hodes R; Mathews C; Morroni C; Hoffman M
Reprod Health Matters; 2016 Nov; 24(48):79-89. PubMed ID: 28024682
[TBL] [Abstract][Full Text] [Related]
9. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
Zaratti L; Senatore S; Franco E
Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
[TBL] [Abstract][Full Text] [Related]
10. The prevention of cervical cancer in Africa.
Fiander AN
Womens Health (Lond); 2011 Jan; 7(1):121-32. PubMed ID: 21175396
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
12. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
13. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.
de Blasio BF; Neilson AR; Klemp M; Skjeldestad FE
J Public Health (Oxf); 2012 Dec; 34(4):539-47. PubMed ID: 22707556
[TBL] [Abstract][Full Text] [Related]
14. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
[TBL] [Abstract][Full Text] [Related]
15. Universal cervical cancer control through a right to health lens: refocusing national policy and programmes on underserved women.
Perehudoff K; Vermandere H; Williams A; Bautista-Arredondo S; De Paepe E; Dias S; Gama A; Keygnaert I; Longatto-Filho A; Ortiz J; Padalko E; Reis RM; Vanderheijden N; Vega B; Verberckmoes B; Degomme O
BMC Int Health Hum Rights; 2020 Jul; 20(1):21. PubMed ID: 32736623
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
[TBL] [Abstract][Full Text] [Related]
18. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
19. Introduction of human papillomavirus vaccination in Nordic countries.
Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
